Compounds > tyrosine

tyrosine and Thyroid Neoplasms

tyrosine has been researched along with Thyroid Neoplasms in 65 studies

Research

Studies (65)

TimeframeStudies, this research(%)All Research%
pre-199018 (27.69)18.7374
1990's7 (10.77)18.2507
2000's28 (43.08)29.6817
2010's6 (9.23)24.3611
2020's6 (9.23)2.80

Authors

AuthorsStudies
Bianchini, A; Bizzarri, G; Coccaro, C; Deiana, MG; Guglielmi, R; Monti, S; Papini, E; Persichetti, A; Presciuttini, F; Triggiani, V1
MacPherson, DS; McPhee, SA; Ulijn, RV; Zeglis, BM1
Chin, L; Han, H; Ma, X; Zhu, Z1
Guo, F; Hasegawa, A; Hiroshima, K; Katoh, R; Nagasaka, T; Nakazawa, T; Wu, D; Yoshida, K1
Hellmann, A; Korczynska, J; Mika, A; Taciak, A; Turyn, J; Zwara, A1
Enomoto, K; Gunduz, M; Hotomi, M; Muragaki, Y; Onoda, N; Sato, F; Tamagawa, S; Uchino, S1
Dong, S; Dong, W; Liu, J; Shen, Y; Zhang, J; Zhang, L; Zhou, H1
Madhuri, R; Patra, S; Roy, E; Sharma, PK1
Cheng, SY; Park, JW; Willingham, MC; Zhao, L1
Huang, J; Mei, W; Wang, K; Zheng, X1
Bongarzone, I; Cassinelli, G; Cremona, M; Cuccuru, G; Gorla, L; Lanzi, C; Miccichè, F; Mondellini, P; Pierotti, MA1
Hirokawa, M; Kodama, R; Miyauchi, A; Nakamura, Y; Sanke, T; Takamura, Y; Yasuoka, H1
Bai, XH; De Falco, V; Kapus, A; Liu, M; Lodyga, M; Melillo, RM; Santoro, M1
Bendlova, B; Bilek, R; Dvorakova, K; Dvorakova, S; Skaba, R; Sykorova, V; Vaclavikova, E; Vlcek, P; Zelinka, T1
Santoro, M; Wells, SA1
Cho, NL; Du, J; Ito, H; Lin, CI; Moore, FD; Ruan, DT; Whang, EE1
Almeida, A; Bromberg, JF; Couto, JP; Daly, L; Soares, P; Sobrinho-Simões, M1
Balsalobre, MD; Carbonell, P; Glower, G; Parrilla, P; Pomares, F; Ríos, A; Rodríguez, GJ; Sola, J; Tébar, J; Torregrosa, NM1
Dinauer, C; Fenton, C; Francis, GL; Patel, A; Powers, PA; Terrell, R; Tuttle, RM1
Chung, HK; Hemmings, BA; Hwang, ES; Hwang, IY; Hwang, JH; Kim, DW; Kim, H; Kim, JM; Park, J; Park, KC; Shong, M; Song, JH; Suh, JM1
JONES, EE; LIU, A; PITTMAN, CS1
LEMARCHAND BERAUD, T; SCAZZIGA, BR; VANNOTTI, A1
HALES, IB; MYHILL, J; REEVE, TS; RICHARDS, M; STANLEY, PG1
Brockman, D; Fagin, JA; Kim, HW; Knauf, JA; Millhorn, DE; Mitsutake, N; Moretti, S; Myatt, L; Puxeddu, E; Seta, KA1
Basolo, F; Castellone, MD; Celetti, A; Cirafici, AM; Curcio, F; Fusco, A; Giannini, R; Guarino, V; Kruhoffer, M; Medico, E; Melillo, RM; Orntoft, TF; Santoro, M1
Ain, KB; Dziba, JM1
Gavrilov, VB; Konev, SV; Lobko, NF1
Chung, HK; Hwang, ES; Hwang, JH; Jung, HS; Kim, DW; Kim, JM; Park, KC; Park, SH; Park, YJ; Shong, M; Song, JH; Suh, JM; Yun, HJ1
Greco, A; Miranda, C; Pagliardini, S; Pierotti, MA; Raho, G; Roccato, E1
Chiariotti, L; Florio, T; Fusco, A; Iuliano, R; Pera, IL; Santoro, M; Schettini, G; Susini, C; Trapasso, F; Viglietto, G1
Chung, HK; Hwang, JH; Jo, KW; Jo, YS; Jung, HS; Kim, DW; Park, JS; Park, KC; Park, SH; Shong, M; Song, JH1
Chan, EC; Chang, CA; Chen, KT; Lin, JD; Liou, MJ; Weng, HF1
Du, L; Kim, LT; Nwariaku, FE; Panta, GR1
Kitahara, S; Matsubara, O; Murakawa, T; Tanabe, T; Tanimoto, T; Tsuda, H1
Kakudo, K; Miyauchi, A; Nakamura, M; Nakamura, Y; Takamura, Y; Yasuoka, H; Zuo, H1
Acunzo, M; Carlomagno, F; Carlomagno, SM; Catania, A; Chiariello, M; Iavarone, C; Melillo, RM; Santoro, M1
Becherini, L; Cantini, G; Ercolino, T; Gaglianò, MS; Lombardi, A; Luconi, M; Mannelli, M; Piscitelli, E; Serio, M1
Hosain, H; Spencer, RP1
Arighi, E; Bongarzone, I; Borrello, MG; Carcano, C; Della Porta, G; Ferraresi, G; Mondellini, P; Monzini, N; Pierotti, MA1
Beinfeld, MC1
Ceccherini, I; Elisei, R; Mancusi, F; Martino, E; Molinaro, E; Pacini, F; Pinchera, A; Romei, C; Romeo, G1
Asai, N; Ito, S; Iwashita, T; Murakami, H; Takahashi, M1
Bergström, JD; Diaz de Ståhl, T; Heldin, NE; Hermansson, A1
Arena, N; de Luca, A; Medico, E; Sena, LM1
Dinauer, CA; Fenton, C; Gary, FL; Nikiforov, YE; Patel, A; Ramirez, R; Tuttle, RM1
Barone, MV; Chiappetta, G; Fenzi, G; Fusco, A; Melillo, RM; Mineo, A; Salvatore, D; Salvatore, G; Santoro, M; Vecchio, G1
Fenzi, G; Fusco, A; Melillo, RM; Monaco, C; Salvatore, D; Santoro, M; Vecchio, G; Visconti, R1
Alberti, L; Arighi, E; Borrello, MG; Ghizzoni, S; Gishizky, ML; Mercalli, E; Pierotti, MA; Radice, MT; Sangregorio, R1
Frasca, F; Vella, V; Vigneri, P; Vigneri, R; Wang, JY1
Blanes, A; de Miguel, M; Diaz-Cano, SJ; Tashjian, R; Wolfe, HJ1
Shimaoka, K; Volpert, EM1
Prezyma, AP; Volpert, EM1
Bongarzone, I; Borrello, MG; Della Porta, G; Fusco, A; Gambetta, RA; Grieco, M; Lanzi, C; Migliazza, A; Santoro, M; Zunino, F1
Magner, JA; Miura, Y; Perkel, VS1
Felts, JH; King, JS1
Atkins, FL; Beaven, MA; Keiser, HR1
Lemarchand-Béraud, T; Valenta, L1
Ewen, SW; Pearse, AG; Polak, JM1
Berger, J; Bouhnik, J; Etling, N1
Lissitzky, S; Rolland, M; Roques, M; Torresani, J; Valenta, L1
Ling, RC; Wu, C1
Etling, N; Lumbroso, P; Vallée, G1
Werner, SC1
Kusakabe, T; Miyake, T1
Jones, JE; Shultz, JS1

Reviews

1 review(s) available for tyrosine and Thyroid Neoplasms

ArticleYear
Targeting the RET pathway in thyroid cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Dec-01, Volume: 15, Issue:23

    Topics: Alleles; Clinical Trials as Topic; Dimerization; Humans; Medical Oncology; Models, Biological; Mutation; Phenotype; Phosphorylation; Point Mutation; Protein Binding; Proto-Oncogene Proteins c-ret; Signal Transduction; Thyroid Neoplasms; Tyrosine

2009

Other Studies

64 other study(ies) available for tyrosine and Thyroid Neoplasms

ArticleYear
Combined Treatment with Laser Ablation and Tyrosine-Kinase Inhibitor as A Novel Multimodality Approach to Locally Advanced Thyroid Cancer: A Case Report.
    Endocrine, metabolic & immune disorders drug targets, 2022, Volume: 22, Issue:3

    Topics: Aged; Female; Humans; Iodine Radioisotopes; Laser Therapy; Protein Kinase Inhibitors; Thyroid Neoplasms; Tyrosine

2022
The Impact of Tyrosine Iodination on the Aggregation and Cleavage Kinetics of MMP-9-Responsive Peptide Sequences.
    ACS biomaterials science & engineering, 2022, 02-14, Volume: 8, Issue:2

    Topics: Halogenation; Humans; Iodine Radioisotopes; Kinetics; Matrix Metalloproteinase 9; Peptides; Thyroid Neoplasms; Tyrosine

2022
A Novel Germline Deletion of p.C630 in RET Causes MTC and Promotes Cell Proliferation and Sensitivity to Pralsetinib.
    The Journal of clinical endocrinology and metabolism, 2022, 08-18, Volume: 107, Issue:9

    Topics: Carcinoma, Neuroendocrine; Cell Proliferation; Germ Cells; Germ-Line Mutation; Humans; Ligands; Male; Middle Aged; Proto-Oncogene Proteins c-ret; Pyrazoles; Pyridines; Pyrimidines; Thyroid Neoplasms; Tyrosine

2022
Expression of T-cell immunoreceptor with immunoglobulin and tyrosine-based inhibitory motif domains (TIGIT) in anaplastic thyroid carcinoma.
    BMC endocrine disorders, 2022, Aug-15, Volume: 22, Issue:1

    Topics: Adenocarcinoma, Follicular; Carcinoma, Neuroendocrine; Humans; Immunoglobulins; Receptors, Immunologic; T-Lymphocytes; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tyrosine

2022
Alterations in the amino acid profile in patients with papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
    Frontiers in endocrinology, 2023, Volume: 14

    Topics: Alanine; Amino Acids; Antibodies; Arginine; Glutamic Acid; Glycine; Hashimoto Disease; Humans; Lysine; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tyrosine

2023
A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1.
    Scientific reports, 2019, 10-10, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Mice; Molecular Targeted Therapy; Signal Transduction; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; TOR Serine-Threonine Kinases; Tyrosine; Xenograft Model Antitumor Assays

2019
Identification of Potential Biomarkers for Thyroid Cancer Using Bioinformatics Strategy: A Study Based on GEO Datasets.
    BioMed research international, 2020, Volume: 2020

    Topics: Androstenes; Biomarkers, Tumor; Clofazimine; Computational Biology; Databases, Genetic; Exosomes; Extracellular Matrix Proteins; Eye Proteins; Fibronectins; Gene Expression Regulation, Neoplastic; Gene Ontology; Gene Regulatory Networks; Genetic Markers; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; Heparin; Hexamethonium; Humans; Lactams; Nerve Tissue Proteins; Prognosis; Protein Interaction Maps; Receptors, Vasopressin; Signal Transduction; Thyroid Hormones; Thyroid Neoplasms; Transcriptome; Transforming Growth Factor beta; Tumor Suppressor Protein p53; Tyrosine

2020
Imprinted ZnO nanostructure-based electrochemical sensing of calcitonin: a clinical marker for medullary thyroid carcinoma.
    Analytica chimica acta, 2015, Jan-01, Volume: 853

    Topics: Amino Acid Sequence; Biomarkers, Tumor; Calcitonin; Carcinoma, Neuroendocrine; Chemistry Techniques, Analytical; Electric Impedance; Electrochemistry; Humans; Molecular Imprinting; Molecular Sequence Data; Molecular Weight; Nanostructures; Polymerization; Polymers; Thyroid Neoplasms; Time Factors; Tyrosine; Zinc Oxide

2015
Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
    Molecular carcinogenesis, 2017, Volume: 56, Issue:2

    Topics: Animals; Cell Line; Cell Line, Tumor; Cell Proliferation; Female; Genes, Tumor Suppressor; Humans; Mice; Mice, Nude; Phosphorylation; Point Mutation; Rats; Thyroid Gland; Thyroid Hormone Receptors beta; Thyroid Neoplasms; Tyrosine

2017
Cell Transformation by PTP1B Truncated Mutants Found in Human Colon and Thyroid Tumors.
    PloS one, 2016, Volume: 11, Issue:11

    Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Transformation, Neoplastic; Colonic Neoplasms; Enzyme Activation; Fibroblasts; Humans; Mutant Proteins; Mutation; Phosphorylation; Protein Isoforms; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Receptor, IGF Type 1; Signal Transduction; src-Family Kinases; Thyroid Neoplasms; Tumor Stem Cell Assay; Tyrosine

2016
Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements.
    Molecular carcinogenesis, 2009, Volume: 48, Issue:3

    Topics: Animals; Antineoplastic Agents; Carcinoma, Medullary; Epidermal Growth Factor; ErbB Receptors; Female; Gefitinib; Germ-Line Mutation; Humans; Mice; Mice, Nude; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Oncogene Proteins; Phosphorylation; Proteomics; Proto-Oncogene Proteins c-ret; Quinazolines; Signal Transduction; Thyroid Neoplasms; Tyrosine

2009
CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis.
    BMC cancer, 2008, Sep-30, Volume: 8

    Topics: Carcinoma, Papillary; Cell Line, Tumor; Chemokine CXCL12; Enzyme Inhibitors; Humans; Immunohistochemistry; Lymphatic Metastasis; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitrites; Nitroso Compounds; Receptors, CXCR4; RNA, Messenger; Thyroid Neoplasms; Tyrosine

2008
XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway.
    Oncogene, 2009, Feb-19, Volume: 28, Issue:7

    Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Blotting, Northern; Bromodeoxyuridine; Carcinoma, Papillary; Cell Proliferation; Flow Cytometry; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oncogene Proteins, Fusion; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Thyroid Neoplasms; Tumor Cells, Cultured; Tyrosine

2009
RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest.
    Endocrine, 2009, Volume: 36, Issue:3

    Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Carcinoma, Medullary; Child; Disease; Family; Female; Genetic Association Studies; Germ-Line Mutation; Hirschsprung Disease; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neural Crest; Phenylalanine; Polymorphism, Single Nucleotide; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Thyroid Neoplasms; Tyrosine; Young Adult

2009
Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers.
    Biochemical and biophysical research communications, 2012, May-11, Volume: 421, Issue:3

    Topics: Adenocarcinoma, Papillary; Cell Proliferation; Dasatinib; High-Throughput Screening Assays; Humans; Metabolome; Molecular Targeted Therapy; Mutation; Neoplasm Invasiveness; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles; Thyroid Neoplasms; Tumor Cells, Cultured; Tyrosine; Up-Regulation

2012
AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines.
    PloS one, 2012, Volume: 7, Issue:10

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Female; Humans; Mice; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Pyrazoles; Pyrimidines; Signal Transduction; Thyroid Neoplasms; TOR Serine-Threonine Kinases; Tyrosine; Xenograft Model Antitumor Assays

2012
Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center.
    Journal of the American College of Surgeons, 2002, Volume: 195, Issue:2

    Topics: Adolescent; Adult; Calcitonin; Child; Child, Preschool; Cysteine; Drosophila Proteins; Female; Humans; Infant; Male; Multiple Endocrine Neoplasia Type 2a; Mutation; Neoplasm Recurrence, Local; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Function Tests; Thyroid Neoplasms; Thyroidectomy; Tyrosine

2002
Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents.
    Journal of endocrinological investigation, 2002, Volume: 25, Issue:8

    Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Carcinoma, Papillary; Child; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Thyroid Neoplasms; Tyrosine

2002
RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
    Molecular endocrinology (Baltimore, Md.), 2003, Volume: 17, Issue:7

    Topics: 3-Phosphoinositide-Dependent Protein Kinases; Amino Acid Sequence; Animals; Carcinoma, Papillary; CHO Cells; Cricetinae; Enzyme Inhibitors; Fibroblasts; Humans; Mice; Molecular Sequence Data; Nuclear Receptor Coactivators; Oncogene Proteins; Oncogene Proteins, Fusion; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Signal Transduction; src-Family Kinases; Thyroid Neoplasms; Transcription Factors; Transcriptional Activation; Tumor Suppressor Protein p53; Tyrosine

2003
HORMONE SYNTHESIS BY A TRANSPLANTABLE THYROID TUMOR IN MICE.
    Endocrinology, 1963, Volume: 73

    Topics: Adenoma; Chromatography; Diiodotyrosine; Iodine Isotopes; Metabolism; Mice; Neoplasms, Experimental; Propylthiouracil; Research; Thyroid Neoplasms; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine; Tyrosine

1963
[PLASMATIC IODINATED PRODUCTS IN THYROID DISEASES].
    Exposes annuels de biochimie medicale, 1964, Volume: 25

    Topics: Autoradiography; Blood Chemical Analysis; Chromatography; Diiodotyrosine; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Metabolic Diseases; Thyroid Function Tests; Thyroid Neoplasms; Thyroiditis; Thyroxine; Triiodothyronine; Tyrosine

1964
FUNCTIONING FOLLICULAR METASTATIC CARCINOMA OF THE THYROID.
    The Medical journal of Australia, 1964, Oct-31, Volume: 2

    Topics: Carcinoma; Humans; Iodine Isotopes; Neoplasm Metastasis; Neoplasms; Pathology; Pharmacology; Thoracic Neoplasms; Thyroid Function Tests; Thyroid Neoplasms; Thyroidectomy; Thyroxine; Tyrosine

1964
Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway.
    The Journal of biological chemistry, 2003, Dec-26, Volume: 278, Issue:52

    Topics: Animals; Blotting, Northern; Carcinoma, Papillary; Cell Line; Chromatography, High Pressure Liquid; Culture Media, Conditioned; Cyclooxygenase 2; Dinoprostone; Disease Progression; Dose-Response Relationship, Drug; Eicosanoids; Gene Library; Humans; Hydroxyeicosatetraenoic Acids; Intramolecular Oxidoreductases; Isoenzymes; Membrane Proteins; Mutation; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Rats; Receptor Protein-Tyrosine Kinases; RNA, Messenger; Thyroid Neoplasms; Time Factors; Transcription, Genetic; Transcriptional Activation; Tyrosine; Up-Regulation

2003
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells.
    Oncogene, 2004, Mar-18, Volume: 23, Issue:12

    Topics: Carcinoma, Papillary; Cell Division; Cell Line, Tumor; Cell Transformation, Neoplastic; Collagen; Collagen Type I; DNA; Drug Combinations; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Laminin; Neoplasm Invasiveness; Osteopontin; Phenotype; Phosphorylation; Protein Structure, Tertiary; Proteoglycans; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Recombinant Proteins; Sialoglycoproteins; Signal Transduction; Thyroid Neoplasms; Tyrosine

2004
Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic thyroid carcinoma cell growth in vitro.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:5

    Topics: Antineoplastic Agents; Benzamides; Carcinoma; Cell Cycle; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression; Genes, abl; Humans; Imatinib Mesylate; Oncogene Proteins; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Thyroid Neoplasms; Tyrosine

2004
[Determination of tyrosine- and tryptophan-containing peptides in plasma by absorption in UV spectral region].
    Klinicheskaia laboratornaia diagnostika, 2004, Issue:3

    Topics: Humans; Hydrogen-Ion Concentration; Oligopeptides; Postoperative Period; Spectrophotometry, Ultraviolet; Thyroid Neoplasms; Thyroxine; Tryptophan; Tyrosine

2004
Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
    Molecular endocrinology (Baltimore, Md.), 2004, Volume: 18, Issue:11

    Topics: Carcinoma, Papillary; DNA-Binding Proteins; Genes, MHC Class II; HLA-DR Antigens; Humans; Interferon Regulatory Factor-1; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Nuclear Proteins; Oncogene Proteins; Oncogene Proteins, Fusion; Phosphoproteins; Phosphorylation; Promoter Regions, Genetic; Protein Inhibitors of Activated STAT; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; RNA, Messenger; Signal Transduction; Small Ubiquitin-Related Modifier Proteins; STAT1 Transcription Factor; Thyroid Neoplasms; Trans-Activators; Transcriptional Activation; Tyrosine

2004
Analysis of SHP-1-mediated down-regulation of the TRK-T3 oncoprotein identifies Trk-fused gene (TFG) as a novel SHP-1-interacting protein.
    The Journal of biological chemistry, 2005, Feb-04, Volume: 280, Issue:5

    Topics: Animals; Catalysis; Down-Regulation; Enzyme Activation; Humans; Intracellular Signaling Peptides and Proteins; Kidney; Mice; Mutagenesis; NIH 3T3 Cells; Protein Structure, Tertiary; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Proteins; Receptor, trkA; Thyroid Neoplasms; Tyrosine

2005
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.
    Oncogene, 2005, Apr-28, Volume: 24, Issue:19

    Topics: Animals; Blotting, Western; Cell Adhesion; CSK Tyrosine-Protein Kinase; Cytoskeletal Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Glutathione Transferase; Humans; Immunoblotting; Immunoprecipitation; Mutation; Neoplasms; Paxillin; Peptides; Phenotype; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Binding; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Rats; Receptor-Like Protein Tyrosine Phosphatases, Class 3; src-Family Kinases; Thyroid Gland; Thyroid Neoplasms; Transfection; Tyrosine

2005
Regulation of protein kinase B tyrosine phosphorylation by thyroid-specific oncogenic RET/PTC kinases.
    Molecular endocrinology (Baltimore, Md.), 2005, Volume: 19, Issue:11

    Topics: Animals; Carcinoma, Papillary; Cells, Cultured; Cytoplasm; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Thyroid Gland; Thyroid Neoplasms; Tyrosine

2005
An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines.
    Cancer letters, 2006, Jan-18, Volume: 231, Issue:2

    Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Autocrine Communication; Blotting, Western; Cell Proliferation; DNA, Complementary; Enzyme Activation; Gene Expression Profiling; Humans; Oligonucleotide Array Sequence Analysis; Phosphorylation; Platelet-Derived Growth Factor; Receptor, Platelet-Derived Growth Factor alpha; RNA, Messenger; Thyroid Neoplasms; Tumor Cells, Cultured; Tyrosine; Tyrphostins

2006
Direct phosphorylation of proliferative and survival pathway proteins by RET.
    Surgery, 2005, Volume: 138, Issue:2

    Topics: Carcinoma, Medullary; Cell Line, Tumor; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Signal Transduction; Thyroid Neoplasms; Tyrosine

2005
Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach.
    Pathology international, 2005, Volume: 55, Issue:12

    Topics: Antigens, Neoplasm; Carcinoma, Papillary; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; DNA-Binding Proteins; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Receptor, ErbB-2; RNA, Messenger; Thyroid Neoplasms; Tyrosine

2005
Nitric oxide in papillary thyroid carcinoma: induction of vascular endothelial growth factor D and correlation with lymph node metastasis.
    The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:4

    Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; RNA, Messenger; Thyroid Neoplasms; Tyrosine; Vascular Endothelial Growth Factor D

2006
Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene.
    The Journal of biological chemistry, 2006, Apr-14, Volume: 281, Issue:15

    Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Blotting, Western; Cell Line; Cell Line, Tumor; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Genes, Reporter; Genetic Vectors; Humans; MAP Kinase Signaling System; Mice; Molecular Sequence Data; Mutation; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Protein Structure, Tertiary; Proto-Oncogene Mas; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-ret; Signal Transduction; src-Family Kinases; Thyroid Neoplasms; Transfection; Tyrosine

2006
The Y606C RET mutation causes a receptor gain of function.
    Clinical endocrinology, 2008, Volume: 69, Issue:2

    Topics: Amino Acid Substitution; Animals; Base Sequence; Carcinoma, Medullary; Cysteine; Female; Germ-Line Mutation; Humans; Mice; Middle Aged; Multiple Endocrine Neoplasia Type 2a; NIH 3T3 Cells; Proto-Oncogene Proteins c-ret; Thyroid Neoplasms; Tyrosine

2008
Thionamides and analogues: a reapraisal of antithyroid and thyroid carcinogenic effects.
    Medical hypotheses, 1980, Volume: 6, Issue:2

    Topics: Antithyroid Agents; Carcinogens; Chemical Phenomena; Chemistry; Pyridines; Structure-Activity Relationship; Thiobarbiturates; Thiones; Thiourea; Thyroid Hormones; Thyroid Neoplasms; Tyrosine

1980
Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.
    Molecular and cellular biology, 1993, Volume: 13, Issue:1

    Topics: 3T3 Cells; Amino Acid Sequence; Animals; Base Sequence; Blotting, Western; Cell Transformation, Neoplastic; Cloning, Molecular; DNA; Drosophila Proteins; Gene Expression Regulation; Gene Rearrangement; Mice; Molecular Sequence Data; Oligodeoxyribonucleotides; Phosphotyrosine; Protein Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Thyroid Neoplasms; Tyrosine

1993
Inhibition of pro-cholecystokinin (CCK) sulfation by treatment with sodium chlorate alters its processing and decreases cellular content and secretion of CCK 8.
    Neuropeptides, 1994, Volume: 26, Issue:3

    Topics: Animals; Carcinoma; Chlorates; Cholecystokinin; Culture Media; Protein Precursors; Rats; Receptors, Cholecystokinin; Sincalide; Sulfates; Sulfur Radioisotopes; Thyroid Neoplasms; Tumor Cells, Cultured; Tyrosine

1994
Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:4

    Topics: Adult; Aged; Amino Acid Sequence; Base Sequence; Calcitonin; Carcinoma, Medullary; Cysteine; DNA; DNA Primers; DNA, Neoplasm; Drosophila Proteins; Exons; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Neoplasm Staging; Point Mutation; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Recurrence; Restriction Mapping; Thyroid Neoplasms; Tyrosine

1996
Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations.
    Journal of internal medicine, 1998, Volume: 243, Issue:6

    Topics: Carcinoma, Medullary; Drosophila Proteins; Hirschsprung Disease; Humans; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Tyrosine

1998
Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture.
    British journal of cancer, 1999, Volume: 80, Issue:5-6

    Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Blotting, Northern; Carcinoma; Enzyme Activation; Humans; Liver Neoplasms; Phosphorylation; Precipitin Tests; Proteins; Proto-Oncogene Proteins c-met; Reverse Transcriptase Polymerase Chain Reaction; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Thyroid Gland; Thyroid Neoplasms; Tumor Cells, Cultured; Tyrosine

1999
Met overexpression confers HGF-dependent invasive phenotype to human thyroid carcinoma cells in vitro.
    Journal of cellular physiology, 1999, Volume: 180, Issue:3

    Topics: Carcinoma; Cell Division; Cell Movement; Drug Resistance, Neoplasm; Hepatocyte Growth Factor; Humans; Neoplasm Invasiveness; Phenotype; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins c-met; Thyroid Neoplasms; Tumor Cells, Cultured; Tyrosine; Wound Healing

1999
Tyrosine kinase expression is increased in papillary thyroid carcinoma of children and young adults.
    Frontiers in bioscience : a journal and virtual library, 2000, Mar-01, Volume: 5

    Topics: Adolescent; Adult; Carcinoma, Papillary; Child; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphokines; Male; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Registries; Thyroid Neoplasms; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors

2000
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:10

    Topics: Amino Acid Sequence; Animals; Antibodies, Blocking; COS Cells; DNA; Drosophila Proteins; Fibroblasts; Humans; Immunohistochemistry; Microinjections; Molecular Sequence Data; Oncogene Proteins; Oncogenes; Phosphorylation; Point Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Transfection; Tumor Cells, Cultured; Tyrosine

2000
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.
    Cancer research, 2001, Feb-15, Volume: 61, Issue:4

    Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; COS Cells; Drosophila Proteins; Enzyme Activation; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; ras Proteins; Rats; Receptor Protein-Tyrosine Kinases; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Thyroid Neoplasms; Tyrosine

2001
Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein.
    Oncogene, 2001, Jun-14, Volume: 20, Issue:27

    Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Amino Acid Sequence; Amino Acid Substitution; Animals; Carcinoma, Papillary; Cell Line; Cell Transformation, Neoplastic; Chlorocebus aethiops; COS Cells; Drosophila Proteins; Humans; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Oncogenes; Protein Isoforms; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Recombinant Proteins; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; src Homology Domains; Thyroid Neoplasms; Transfection; Tyrosine

2001
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor.
    Oncogene, 2001, Jun-28, Volume: 20, Issue:29

    Topics: Antineoplastic Agents; Benzamides; Cell Movement; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Extracellular Matrix; Hepatocyte Growth Factor; Humans; Imatinib Mesylate; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Morphogenesis; Phosphorylation; Piperazines; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Pyrimidines; Thyroid Gland; Thyroid Neoplasms; Tumor Cells, Cultured; Tyrosine

2001
Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:8

    Topics: Amino Acid Substitution; Antigens, Nuclear; Autoantigens; Calcitonin; Carcinoma, Medullary; Cysteine; DNA Primers; Drosophila Proteins; Female; Focal Epithelial Hyperplasia; Genes, Retinoblastoma; Germ-Line Mutation; Humans; Ki-67 Antigen; Loss of Heterozygosity; Multiple Endocrine Neoplasia Type 2a; Nerve Tissue Proteins; Neurofibromin 1; Nuclear Proteins; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Diseases; Thyroid Neoplasms; Thyroidectomy; Tyrosine

2001
Iodoamino acids in abnormal and grossly normal thyroids: Comparison between 125I and 127I distribution.
    Journal of medicine, 1977, Volume: 8, Issue:3-4

    Topics: Adenoma; Adult; Aged; Amino Acids; Carcinoma, Papillary; Cysts; Female; Goiter, Nodular; Humans; Iodine Isotopes; Iodine Radioisotopes; Isotope Labeling; Male; Middle Aged; Thyroid Diseases; Thyroid Gland; Thyroid Hormones; Thyroid Neoplasms; Thyroxine; Triiodothyronine; Tyrosine

1977
Transplantable thyroid tumour in rats: iodoamino acid distribution in successive tumour generations.
    Acta endocrinologica, 1977, Volume: 85, Issue:1

    Topics: Amino Acids; Animals; Diiodotyrosine; Female; Iodine Radioisotopes; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Thyroid Hormones; Thyroid Neoplasms; Thyroxine; Time Factors; Triiodothyronine; Tyrosine

1977
Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
    Oncogene, 1992, Volume: 7, Issue:11

    Topics: 3T3 Cells; Animals; Blotting, Western; Carcinoma, Papillary; Drosophila Proteins; Gene Rearrangement; Humans; Mice; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Tetradecanoylphorbol Acetate; Thyroid Neoplasms; Tyrosine

1992
Rates of processing of the high mannose oligosaccharide units at the three glycosylation sites of mouse thyrotropin and the two sites of free alpha-subunits.
    Endocrinology, 1988, Volume: 123, Issue:3

    Topics: Amino Acid Sequence; Animals; Carbon Radioisotopes; Glycoprotein Hormones, alpha Subunit; Glycosylation; Kinetics; Macromolecular Substances; Mannose; Mice; Oligosaccharides; Pituitary Hormones, Anterior; Protein Processing, Post-Translational; Thyroid Neoplasms; Thyrotropin; Tritium; Tyrosine

1988
Enhanced excretion of free amino acids by hyperthyroid patients.
    Clinical chemistry, 1971, Volume: 17, Issue:5

    Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Amino Acids; Aminoisobutyric Acids; Calcium; Cholesterol; Exophthalmos; Fasting; Female; Humans; Hyperthyroidism; Iodine Radioisotopes; Male; Middle Aged; Phosphorus; Renal Aminoacidurias; Thyroid Function Tests; Thyroid Neoplasms; Tyrosine

1971
Dopa decarboxylase in medullary carcinoma of the thyroid.
    The New England journal of medicine, 1973, Sep-13, Volume: 289, Issue:11

    Topics: Adrenal Gland Neoplasms; Amine Oxidase (Copper-Containing); Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Carcinoma; Cresols; Dihydroxyphenylalanine; Dopa Decarboxylase; Histamine; Histidine; Humans; Hydrazines; Hydroxylamines; Methyldopa; Methylhistidines; Norepinephrine; Pheochromocytoma; Serotonin; Thyroid Gland; Thyroid Neoplasms; Tryptophan; Tyrosine; Tyrosine 3-Monooxygenase

1973
Thyroglobulin and thyroid acid protease activity in thyroid disease.
    The Journal of clinical endocrinology and metabolism, 1970, Volume: 31, Issue:4

    Topics: Adenoma; Fluorometry; Graves Disease; Humans; Hydrogen-Ion Concentration; Iodine; Peptide Hydrolases; Proteins; Spectrophotometry; Thyroglobulin; Thyroid Diseases; Thyroid Function Tests; Thyroid Gland; Thyroid Neoplasms; Thyroiditis, Autoimmune; Thyroxine; Tyrosine

1970
The genesis of apudamyloid in endocrine polypeptide tumours: histochemical distinction from immunamyloid.
    Virchows Archiv. B, Cell pathology, 1972, Volume: 10, Issue:2

    Topics: Adenocarcinoma, Scirrhous; Adenoma, Islet Cell; Adrenal Gland Neoplasms; Amyloidosis; Arthritis, Rheumatoid; Carcinoma; Endocrine System Diseases; Histocytochemistry; Humans; Microscopy, Electron; Neoplasm Proteins; Neoplasms; Pancreatic Neoplasms; Pheochromocytoma; Thyroid Neoplasms; Tryptophan Oxygenase; Tyrosine

1972
[Action "in vitro" of 2 histological fixatives on the iodine content of human thyroid tissue].
    Revue francaise d'etudes cliniques et biologiques, 1968, Volume: 13, Issue:9

    Topics: Adenoma; Autoradiography; Chromatography; Goiter; Histological Techniques; Humans; In Vitro Techniques; Iodine Radioisotopes; Methods; Monoiodotyrosine; Thyroid Gland; Thyroid Hormones; Thyroid Neoplasms; Tyrosine

1968
Human thyroglobulin. Physicochemical properties in relation to iodine content.
    Biochimica et biophysica acta, 1968, Dec-03, Volume: 168, Issue:3

    Topics: Adenoma; Animals; Carcinoma; Centrifugation, Density Gradient; Chemical Precipitation; Chromatography, Ion Exchange; Electrophoresis, Disc; Goiter; Humans; Hydrogen-Ion Concentration; Immunodiffusion; Iodine; Iodine Isotopes; Sheep; Thyroglobulin; Thyroid Neoplasms; Tyrosine; Ultracentrifugation

1968
Determination of iodoamino acids and inorganic iodide by thin-layer chromatography.
    Analytical biochemistry, 1970, Volume: 37, Issue:2

    Topics: Alcohols; Animals; Butanones; Chromatography, Thin Layer; Diiodotyrosine; Iodides; Iodine; Iodine Isotopes; Methods; Monoiodotyrosine; Quaternary Ammonium Compounds; Rats; Thyroid Gland; Thyroid Hormones; Thyroid Neoplasms; Thyroxine; Triiodothyronine; Tyrosine

1970
[Study of compounds labelled with I-131 present in fluids extracted by puncture from certain hot thyroid nodules].
    Revue francaise d'etudes cliniques et biologiques, 1965, Volume: 10, Issue:4

    Topics: Blood Proteins; Humans; In Vitro Techniques; Iodine Radioisotopes; Neoplasm Proteins; Thyroid Neoplasms; Tyrosine

1965
Radioiodine tests of thyroid function and thyroid-scanning--a critical review.
    Nuclear-Medizin, 1965

    Topics: Autoradiography; Diiodotyrosine; Humans; Iodine Radioisotopes; Thyroid Function Tests; Thyroid Neoplasms; Thyrotropin; Triiodothyronine; Tyrosine

1965
Iodotyrosine deiodinase isozymes in the normal and in thyroid diseases.
    The Journal of clinical endocrinology and metabolism, 1966, Volume: 26, Issue:6

    Topics: Electrophoresis; Humans; Hyperthyroidism; In Vitro Techniques; Iodine Isotopes; Isoenzymes; Kidney; Liver; Microsomes; Mitochondria; Thyroid Gland; Thyroid Neoplasms; Tyrosine

1966
Identification of thyroidal iodoamino acids by gel filtration and automated 127-I determination.
    The Journal of clinical endocrinology and metabolism, 1966, Volume: 26, Issue:9

    Topics: Autoanalysis; Chromatography, Gel; Diiodotyrosine; Goiter; Humans; In Vitro Techniques; Iodides; Iodine Radioisotopes; Thyroid Gland; Thyroid Neoplasms; Thyroiditis, Autoimmune; Thyroxine; Triiodothyronine; Tyrosine

1966